Anaplastic Lymphoma Kinase (ALK) Inhibitors

Most Exhaustive Report

Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2018

Anaplastic Lymphoma Kinase (ALK) Inhibitors

Most Exhaustive Report

Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2018

SKU : APA17801 Published on : February 2018 Pages : 70

${{licencetype}}

Get 10% Free Customization
On This Report.
Customize this report Enquire before buying
data center market research

Get actionable insights on how COVID-19 is impacting your business sector.

Enquire now

Anaplastic lymphoma kinase (ALK)

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) belonging to the insulin receptor (IR) superfamily. ALK also known CD246 is encoded by the ALK gene in humans. Immunohistochemical analysis of adult human tissues reveals that ALK expression is sparsely scattered in neural cells, endothelial cells and pericytes in the brain. ALK mRNA is also expressed in the small intestine, testis, prostate, and colon. ALK was initially identified as the product of a gene rearrangement in anaplastic large cell lymphoma (ALCL). ALK was subsequently found to be rearranged, mutated, or amplified in a series of tumors including lymphoma, neuroblastoma, and non-small cell lung cancer (NSCLC). There is strong clinical evidence that ALK is one a key driving factor of oncogenesis, thus making it a key drug target.

Currently marketed ALK inhibitors include Zykadia (ceritinib) and Alecensa (alectinib). These drugs are indicated for the treatment of gastrointestinal cancer and non small cell lung cancer. The ALK inhibitors pipeline has more than 15 molecules and is expected to achieve regulatory approval in foreseeable future, few of which are ensartinib (X-396), X-376, X-390, CEP-28122, EBI-215, EBI-600215, and ASP3026. In pipeline analysis, these are analyzed on the basis of route of administration (ROA) and type of molecule. The pipeline is also assessed based on monotherapy and combination therapy, and different clinical phases including Phase III, Phase II, Phase I and pre-clinical stage. Few key companies which are involved in the development of ALK inhibitors include AstraZeneca, Teva, Delenex Therapeutics, Astellas, Amgen and Tesaro. 

Reasons to Buy

  • To gain erudite insights about the ALK inhibitor pipeline landscape
  • To ascertain unique product development dynamics and leverage it for new target identification, drug repositioning, and precision medicine
  • To optimize the pipeline product portfolio in correspondence with the dynamic pharmaceutical market
  • To identify competitors and design strategic initiatives for drug development activities
  • To understand the market and choose right partners for strategic collaborations
  • To obtain informed updates on drug termination/drug discontinuation 

FILL IN YOUR DETAILS BELOW TO GET FREE SAMPLE OF THIS REPORT

Client Speak

data center market size

Erik Young

CEO, Co-founder
Audink Inc., DBA Audios

The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow.

data center market

Benjamin Arnold

Senior Product Manager
Interstates

I recently purchased a key Arizton Industry Outlook & Forecast in order to better understand growth for specific market segments and the macro environmental factors impacting this growth. I found Ariztonā€™s coverage of the market dynamics and key takeaways to be insightful and valuable. The segmentation breakouts gave me the information I needed to guide strategic considerations.

data center market research

Hallmann, Nickolai

Manager Market Analyst Power
Generation & Energy
Rolls-Royce Power Systems AG

The provided information by Arizton really met my expectations. Especially the deep information about the datacenter ecosystem was very helpful. Furthermore, I absolutely appreciate the optimal service from the key account managers of Arizton. It was always a pleasure working with them.

Customer Service

Support

+1-312-235-2040

Copyright 2019 - Arizton

data center market